Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Q32 Bio (QTTB) Stock Forecast & Price Target

Q32 Bio logo
$6.00 +0.26 (+4.43%)
As of 03:15 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Q32 Bio - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
1
Buy
3

Based on 4 Wall Street analysts who have issued ratings for Q32 Bio in the last 12 months, the stock has a consensus rating of "Buy." Out of the 4 analysts, 1 has given a hold rating, 2 have given a buy rating, and 1 has given a strong buy rating for QTTB.

Consensus Price Target

$13.00
116.49% Upside
According to the 4 analysts' twelve-month price targets for Q32 Bio, the average price target is $13.00. The highest price target for QTTB is $13.00, while the lowest price target for QTTB is $13.00. The average price target represents a forecasted upside of 116.49% from the current price of $6.01.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for QTTB and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Q32 Bio and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

QTTB Analyst Ratings Over Time

TypeCurrent Forecast
5/19/25 to 5/19/26
1 Month Ago
4/19/25 to 4/19/26
3 Months Ago
2/18/25 to 2/18/26
1 Year Ago
5/19/24 to 5/19/25
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
1 Buy rating(s)
0 Buy rating(s)
2 Buy rating(s)
Hold
1 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$13.00$13.00$15.00$24.71
Forecasted Upside116.49% Upside122.22% Upside270.37% Upside1,320.36% Upside
Consensus RatingBuyModerate BuyReduceHold

QTTB Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

QTTB Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Q32 Bio Stock vs. The Competition

TypeQ32 BioMedical CompaniesBroader Market
Consensus Rating Score
3.00
2.30
2.52
Consensus RatingBuyHoldModerate Buy
Predicted Upside115.20% Upside1,743.23% Upside17.34% Upside
News Sentiment Rating
Positive News

See Recent QTTB News
Neutral News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
5/18/2026
Cantor Fitzgerald logo
Cantor Fitzgerald
5 of 5 stars
 Initiated CoverageOverweight
5/11/2026 UpgradeSell (D+)Hold (C-)
5/5/2026
HC Wainwright logo
HC Wainwright
3 of 5 stars
Joseph Pantginis
3 of 5 stars
Reiterated RatingBuy$13.00+160.00%
3/12/2026 UpgradeHoldStrong-Buy
3/12/2025Lower TargetEqual Weight$16.00 ➝ $15.00+700.85%
2/11/2025DowngradeOutperformMarket Perform$22.00 ➝ $3.00-5.66%
2/11/2025DowngradeOverweightNeutral$20.00 ➝ $4.00+25.79%
12/11/2024DowngradeStrong-BuyHold
12/11/2024DowngradeBuyNeutral
12/11/2024 Lower TargetOutperform$80.00 ➝ $20.00-18.07%
12/11/2024 Reiterated RatingStrong-BuyOutperform$90.00 ➝ $22.00-9.87%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 03:17 PM ET.


QTTB Forecast - Frequently Asked Questions

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Q32 Bio is $13.00, with a high forecast of $13.00 and a low forecast of $13.00.

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Q32 Bio in the last year. There is currently 1 hold rating, 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" QTTB shares.

According to analysts, Q32 Bio's stock has a predicted upside of 116.49% based on their 12-month stock forecasts.

Over the previous 90 days, Q32 Bio's stock had 2 upgrades by analysts.

Q32 Bio has been rated by research analysts at Cantor Fitzgerald, HC Wainwright, Weiss Ratings, and Zacks Research in the past 90 days.

Analysts like Q32 Bio more than other "medical" companies. The consensus rating for Q32 Bio is Buy while the average consensus rating for "medical" companies is Hold. Learn more on how QTTB compares to other companies.


This page (NASDAQ:QTTB) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners